Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Human Genetics01:28

Human Genetics

566
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
566
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

338
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
338
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Circulation·2026
Same author

Autonomous biomedical research with an artificial intelligence agent.

Science (New York, N.Y.)·2026
Same author

Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter Registry.

Circulation. Genomic and precision medicine·2026
Same author

Artificial Intelligence-Enabled Cardiac Function Estimation from Phone Videos of Echocardiograms.

medRxiv : the preprint server for health sciences·2026
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

Population-scale detection of methylation outliers from long-read genome sequencing.

medRxiv : the preprint server for health sciences·2026

相关实验视频

Updated: Jul 2, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.0K

对实施心血管药物基因组测试的知识和态度.

Callan Russell1, MaryAnn Campion1, Megan E Grove2

  • 1Department of Genetics, Stanford University, Stanford, California, USA.

Clinical and translational science
|February 29, 2024
PubMed
概括

心脏病提供者表现出适度的药物基因组学知识,但测试订购经验有限. 他们对将药物基因组测试,特别是面板,纳入心血管护理感兴趣.

更多相关视频

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.3K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

相关实验视频

Last Updated: Jul 2, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.0K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.3K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

科学领域:

  • 心血管医学 心血管医学
  • 药物基因组学 药物基因组学
  • 临床遗传学 临床遗传学

背景情况:

  • 药物基因组学在药物治疗中提供了潜在的好处,包括提高疗效和减少不良事件.
  • 提供者对药物基因组测试的了解和采用在不同的医学专业之间有很大的差异.
  • 心血管药物经常受到遗传变异的影响,这突显了心脏病学中需要药物基因组学的洞察力.

研究的目的:

  • 评估心脏病提供者对临床药物基因组测试实施的知识,态度和感知障碍.
  • 了解心脏病提供者对药物基因组学的熟悉程度以及他们愿意订购和解释药物基因组测试的意愿.
  • 探索心脏病学实践中对药物基因组测试格式 (面板与单基因) 的偏好.

主要方法:

  • 一项在线调查分发给61名心脏病提供者,包括药剂师,医生,遗传咨询师和护士.
  • 该调查评估了参与者的先前遗传学教育,熟悉药物基因组学,订购测试的经验,以及对实施的态度.
  • 数据分析的重点是识别知识差距,兴趣水平和在心血管护理中采用药物基因组测试的障碍.

主要成果:

  • 虽然大多数提供者有一些遗传学教育,但只有52%的人感到准备好订购药物基因组测试.
  • 66%的受访者熟悉药物基因组学,其中遗传咨询师的熟悉度最高.
  • 之前只有15%的人订购过测试,但36%的人可能会在未来这样做,89%的人对其纳入心血管遗传测试感兴趣. 84%的人更喜欢面板测试.

结论:

  • 心脏病提供者对药物基因组学有适度的熟悉,但在订购测试方面实践经验有限.
  • 心脏病提供者对将药物基因组测试,特别是基于小组的方法纳入他们的临床实践有很大的兴趣.
  • 需要解决临床实用性的不确定性和后勤挑战等障碍,以促进药物基因组学在心血管医学中的更广泛采用.